 | • レポートコード：MRC2-11QY02518 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は抗菌薬のグローバル市場について調査・分析したレポートです。種類別（セファロスポリン、ペニシリン、フルオロキノロン、マクロライド、カルバペネム、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別抗菌薬の競争状況、市場シェア ・世界の抗菌薬市場：種類別市場規模 2015年-2020年（セファロスポリン、ペニシリン、フルオロキノロン、マクロライド、カルバペネム、その他） ・世界の抗菌薬市場：種類別市場規模予測 2021年-2026年（セファロスポリン、ペニシリン、フルオロキノロン、マクロライド、カルバペネム、その他） ・世界の抗菌薬市場：用途別市場規模 2015年-2020年（病院、診療所、その他） ・世界の抗菌薬市場：用途別市場規模予測 2021年-2026年（病院、診療所、その他） ・北米の抗菌薬市場分析：米国、カナダ ・ヨーロッパの抗菌薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの抗菌薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の抗菌薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの抗菌薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Sanofi、Allergan、GSK、Merck、Pfizer、Sandoz、Teva Pharmaceuticals、Abbott、Johnson & Johnson、Eli Lilly ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Antibacterial drugs refer to the substances that can destroy or inhibit the growth of microorganism such as bacteria. Antibacterial drugs are often termed as antibiotics, and widely used in prevention and treatment of infectious dieses. Various classes of these drugs have been developed, according to the microorganism to be checked. Antibacterial drugs market is driven by increasing prevalence of infectious diseases.
Increase in aged population, growing demand for efficient and affordable antibacterial drugs and increasing number of multi-drug resistant bacterial strains are some of the key factors that are driving the global antibacterial drugs market. In addition, increased prevalence of infectious diseases, that demand for development of innovative molecules or treatment are driving the antibacterial drugs market. However, factors such as rising number of generic drugs for antibacterial activities and patent expiries are restraining the growth of antibacterial market. In addition, less R&D in this field and increased market maturity are restraining the global antibacterial drugs market.
Market Analysis and Insights: Global Antibacterial Drugs Market
The global Antibacterial Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Antibacterial Drugs Scope and Market Size
Antibacterial Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Antibacterial Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Antibacterial Drugs market is segmented into
Cephalosporins
Penicillins
Fluoroquinolones
Macrolides
Carbapenems
Others
Segment by Application, the Antibacterial Drugs market is segmented into
Hospital
Clinics
Others
Regional and Country-level Analysis
The Antibacterial Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Antibacterial Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Antibacterial Drugs Market Share Analysis
Antibacterial Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Antibacterial Drugs business, the date to enter into the Antibacterial Drugs market, Antibacterial Drugs product introduction, recent developments, etc.
The major vendors covered:
Sanofi
Allergan
GSK
Merck
Pfizer
Sandoz
Teva Pharmaceuticals
Abbott
Johnson & Johnson
Eli Lilly
1 Study Coverage
1.1 Antibacterial Drugs Product Introduction
1.2 Market Segments
1.3 Key Antibacterial Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Antibacterial Drugs Market Size Growth Rate by Type
1.4.2 Cephalosporins
1.4.3 Penicillins
1.4.4 Fluoroquinolones
1.4.5 Macrolides
1.4.6 Carbapenems
1.4.7 Others
1.5 Market by Application
1.5.1 Global Antibacterial Drugs Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Antibacterial Drugs Market Size, Estimates and Forecasts
2.1.1 Global Antibacterial Drugs Revenue 2015-2026
2.1.2 Global Antibacterial Drugs Sales 2015-2026
2.2 Global Antibacterial Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Antibacterial Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Antibacterial Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Antibacterial Drugs Competitor Landscape by Players
3.1 Antibacterial Drugs Sales by Manufacturers
3.1.1 Antibacterial Drugs Sales by Manufacturers (2015-2020)
3.1.2 Antibacterial Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Antibacterial Drugs Revenue by Manufacturers
3.2.1 Antibacterial Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Antibacterial Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Antibacterial Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Antibacterial Drugs Revenue in 2019
3.2.5 Global Antibacterial Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Antibacterial Drugs Price by Manufacturers
3.4 Antibacterial Drugs Manufacturing Base Distribution, Product Types
3.4.1 Antibacterial Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Antibacterial Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Antibacterial Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Antibacterial Drugs Market Size by Type (2015-2020)
4.1.1 Global Antibacterial Drugs Sales by Type (2015-2020)
4.1.2 Global Antibacterial Drugs Revenue by Type (2015-2020)
4.1.3 Antibacterial Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Antibacterial Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Antibacterial Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Antibacterial Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Antibacterial Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Antibacterial Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Antibacterial Drugs Market Size by Application (2015-2020)
5.1.1 Global Antibacterial Drugs Sales by Application (2015-2020)
5.1.2 Global Antibacterial Drugs Revenue by Application (2015-2020)
5.1.3 Antibacterial Drugs Price by Application (2015-2020)
5.2 Antibacterial Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Antibacterial Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Antibacterial Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Antibacterial Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Antibacterial Drugs by Country
6.1.1 North America Antibacterial Drugs Sales by Country
6.1.2 North America Antibacterial Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Antibacterial Drugs Market Facts & Figures by Type
6.3 North America Antibacterial Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Antibacterial Drugs by Country
7.1.1 Europe Antibacterial Drugs Sales by Country
7.1.2 Europe Antibacterial Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Antibacterial Drugs Market Facts & Figures by Type
7.3 Europe Antibacterial Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Antibacterial Drugs by Region
8.1.1 Asia Pacific Antibacterial Drugs Sales by Region
8.1.2 Asia Pacific Antibacterial Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Antibacterial Drugs Market Facts & Figures by Type
8.3 Asia Pacific Antibacterial Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Antibacterial Drugs by Country
9.1.1 Latin America Antibacterial Drugs Sales by Country
9.1.2 Latin America Antibacterial Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Antibacterial Drugs Market Facts & Figures by Type
9.3 Central & South America Antibacterial Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Antibacterial Drugs by Country
10.1.1 Middle East and Africa Antibacterial Drugs Sales by Country
10.1.2 Middle East and Africa Antibacterial Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Antibacterial Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Antibacterial Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Description and Business Overview
11.1.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sanofi Antibacterial Drugs Products Offered
11.1.5 Sanofi Related Developments
11.2 Allergan
11.2.1 Allergan Corporation Information
11.2.2 Allergan Description and Business Overview
11.2.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Allergan Antibacterial Drugs Products Offered
11.2.5 Allergan Related Developments
11.3 GSK
11.3.1 GSK Corporation Information
11.3.2 GSK Description and Business Overview
11.3.3 GSK Sales, Revenue and Gross Margin (2015-2020)
11.3.4 GSK Antibacterial Drugs Products Offered
11.3.5 GSK Related Developments
11.4 Merck
11.4.1 Merck Corporation Information
11.4.2 Merck Description and Business Overview
11.4.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Merck Antibacterial Drugs Products Offered
11.4.5 Merck Related Developments
11.5 Pfizer
11.5.1 Pfizer Corporation Information
11.5.2 Pfizer Description and Business Overview
11.5.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Pfizer Antibacterial Drugs Products Offered
11.5.5 Pfizer Related Developments
11.6 Sandoz
11.6.1 Sandoz Corporation Information
11.6.2 Sandoz Description and Business Overview
11.6.3 Sandoz Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Sandoz Antibacterial Drugs Products Offered
11.6.5 Sandoz Related Developments
11.7 Teva Pharmaceuticals
11.7.1 Teva Pharmaceuticals Corporation Information
11.7.2 Teva Pharmaceuticals Description and Business Overview
11.7.3 Teva Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Teva Pharmaceuticals Antibacterial Drugs Products Offered
11.7.5 Teva Pharmaceuticals Related Developments
11.8 Abbott
11.8.1 Abbott Corporation Information
11.8.2 Abbott Description and Business Overview
11.8.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Abbott Antibacterial Drugs Products Offered
11.8.5 Abbott Related Developments
11.9 Johnson & Johnson
11.9.1 Johnson & Johnson Corporation Information
11.9.2 Johnson & Johnson Description and Business Overview
11.9.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Johnson & Johnson Antibacterial Drugs Products Offered
11.9.5 Johnson & Johnson Related Developments
11.10 Eli Lilly
11.10.1 Eli Lilly Corporation Information
11.10.2 Eli Lilly Description and Business Overview
11.10.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Eli Lilly Antibacterial Drugs Products Offered
11.10.5 Eli Lilly Related Developments
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Description and Business Overview
11.1.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sanofi Antibacterial Drugs Products Offered
11.1.5 Sanofi Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Antibacterial Drugs Market Estimates and Projections by Region
12.1.1 Global Antibacterial Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Antibacterial Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Antibacterial Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Antibacterial Drugs Sales Forecast (2021-2026)
12.2.2 North America: Antibacterial Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Antibacterial Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Antibacterial Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Antibacterial Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Antibacterial Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Antibacterial Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Antibacterial Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Antibacterial Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Antibacterial Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Antibacterial Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Antibacterial Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Antibacterial Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Antibacterial Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Antibacterial Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Antibacterial Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Antibacterial Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Antibacterial Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Antibacterial Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Antibacterial Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Antibacterial Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Antibacterial Drugs Market Segments
Table 2. Ranking of Global Top Antibacterial Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Antibacterial Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Cephalosporins
Table 5. Major Manufacturers of Penicillins
Table 6. Major Manufacturers of Fluoroquinolones
Table 7. Major Manufacturers of Macrolides
Table 8. Major Manufacturers of Carbapenems
Table 9. Major Manufacturers of Others
Table 10. Global Antibacterial Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 11. Global Antibacterial Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 12. Global Antibacterial Drugs Sales by Regions 2015-2020 (K Units)
Table 13. Global Antibacterial Drugs Sales Market Share by Regions (2015-2020)
Table 14. Global Antibacterial Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Antibacterial Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 16. Global Antibacterial Drugs Sales Share by Manufacturers (2015-2020)
Table 17. Global Antibacterial Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Antibacterial Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibacterial Drugs as of 2019)
Table 19. Antibacterial Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Antibacterial Drugs Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Antibacterial Drugs Price (2015-2020) (USD/Unit)
Table 22. Antibacterial Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Antibacterial Drugs Product Type
Table 24. Date of International Manufacturers Enter into Antibacterial Drugs Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Antibacterial Drugs Sales by Type (2015-2020) (K Units)
Table 27. Global Antibacterial Drugs Sales Share by Type (2015-2020)
Table 28. Global Antibacterial Drugs Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Antibacterial Drugs Revenue Share by Type (2015-2020)
Table 30. Antibacterial Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 31. Global Antibacterial Drugs Sales by Application (2015-2020) (K Units)
Table 32. Global Antibacterial Drugs Sales Share by Application (2015-2020)
Table 33. North America Antibacterial Drugs Sales by Country (2015-2020) (K Units)
Table 34. North America Antibacterial Drugs Sales Market Share by Country (2015-2020)
Table 35. North America Antibacterial Drugs Revenue by Country (2015-2020) (US$ Million)
Table 36. North America Antibacterial Drugs Revenue Market Share by Country (2015-2020)
Table 37. North America Antibacterial Drugs Sales by Type (2015-2020) (K Units)
Table 38. North America Antibacterial Drugs Sales Market Share by Type (2015-2020)
Table 39. North America Antibacterial Drugs Sales by Application (2015-2020) (K Units)
Table 40. North America Antibacterial Drugs Sales Market Share by Application (2015-2020)
Table 41. Europe Antibacterial Drugs Sales by Country (2015-2020) (K Units)
Table 42. Europe Antibacterial Drugs Sales Market Share by Country (2015-2020)
Table 43. Europe Antibacterial Drugs Revenue by Country (2015-2020) (US$ Million)
Table 44. Europe Antibacterial Drugs Revenue Market Share by Country (2015-2020)
Table 45. Europe Antibacterial Drugs Sales by Type (2015-2020) (K Units)
Table 46. Europe Antibacterial Drugs Sales Market Share by Type (2015-2020)
Table 47. Europe Antibacterial Drugs Sales by Application (2015-2020) (K Units)
Table 48. Europe Antibacterial Drugs Sales Market Share by Application (2015-2020)
Table 49. Asia Pacific Antibacterial Drugs Sales by Region (2015-2020) (K Units)
Table 50. Asia Pacific Antibacterial Drugs Sales Market Share by Region (2015-2020)
Table 51. Asia Pacific Antibacterial Drugs Revenue by Region (2015-2020) (US$ Million)
Table 52. Asia Pacific Antibacterial Drugs Revenue Market Share by Region (2015-2020)
Table 53. Asia Pacific Antibacterial Drugs Sales by Type (2015-2020) (K Units)
Table 54. Asia Pacific Antibacterial Drugs Sales Market Share by Type (2015-2020)
Table 55. Asia Pacific Antibacterial Drugs Sales by Application (2015-2020) (K Units)
Table 56. Asia Pacific Antibacterial Drugs Sales Market Share by Application (2015-2020)
Table 57. Latin America Antibacterial Drugs Sales by Country (2015-2020) (K Units)
Table 58. Latin America Antibacterial Drugs Sales Market Share by Country (2015-2020)
Table 59. Latin Americaa Antibacterial Drugs Revenue by Country (2015-2020) (US$ Million)
Table 60. Latin America Antibacterial Drugs Revenue Market Share by Country (2015-2020)
Table 61. Latin America Antibacterial Drugs Sales by Type (2015-2020) (K Units)
Table 62. Latin America Antibacterial Drugs Sales Market Share by Type (2015-2020)
Table 63. Latin America Antibacterial Drugs Sales by Application (2015-2020) (K Units)
Table 64. Latin America Antibacterial Drugs Sales Market Share by Application (2015-2020)
Table 65. Middle East and Africa Antibacterial Drugs Sales by Country (2015-2020) (K Units)
Table 66. Middle East and Africa Antibacterial Drugs Sales Market Share by Country (2015-2020)
Table 67. Middle East and Africa Antibacterial Drugs Revenue by Country (2015-2020) (US$ Million)
Table 68. Middle East and Africa Antibacterial Drugs Revenue Market Share by Country (2015-2020)
Table 69. Middle East and Africa Antibacterial Drugs Sales by Type (2015-2020) (K Units)
Table 70. Middle East and Africa Antibacterial Drugs Sales Market Share by Type (2015-2020)
Table 71. Middle East and Africa Antibacterial Drugs Sales by Application (2015-2020) (K Units)
Table 72. Middle East and Africa Antibacterial Drugs Sales Market Share by Application (2015-2020)
Table 73. Sanofi Corporation Information
Table 74. Sanofi Description and Major Businesses
Table 75. Sanofi Antibacterial Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 76. Sanofi Product
Table 77. Sanofi Recent Development
Table 78. Allergan Corporation Information
Table 79. Allergan Description and Major Businesses
Table 80. Allergan Antibacterial Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. Allergan Product
Table 82. Allergan Recent Development
Table 83. GSK Corporation Information
Table 84. GSK Description and Major Businesses
Table 85. GSK Antibacterial Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. GSK Product
Table 87. GSK Recent Development
Table 88. Merck Corporation Information
Table 89. Merck Description and Major Businesses
Table 90. Merck Antibacterial Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. Merck Product
Table 92. Merck Recent Development
Table 93. Pfizer Corporation Information
Table 94. Pfizer Description and Major Businesses
Table 95. Pfizer Antibacterial Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 96. Pfizer Product
Table 97. Pfizer Recent Development
Table 98. Sandoz Corporation Information
Table 99. Sandoz Description and Major Businesses
Table 100. Sandoz Antibacterial Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 101. Sandoz Product
Table 102. Sandoz Recent Development
Table 103. Teva Pharmaceuticals Corporation Information
Table 104. Teva Pharmaceuticals Description and Major Businesses
Table 105. Teva Pharmaceuticals Antibacterial Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 106. Teva Pharmaceuticals Product
Table 107. Teva Pharmaceuticals Recent Development
Table 108. Abbott Corporation Information
Table 109. Abbott Description and Major Businesses
Table 110. Abbott Antibacterial Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 111. Abbott Product
Table 112. Abbott Recent Development
Table 113. Johnson & Johnson Corporation Information
Table 114. Johnson & Johnson Description and Major Businesses
Table 115. Johnson & Johnson Antibacterial Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 116. Johnson & Johnson Product
Table 117. Johnson & Johnson Recent Development
Table 118. Eli Lilly Corporation Information
Table 119. Eli Lilly Description and Major Businesses
Table 120. Eli Lilly Antibacterial Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 121. Eli Lilly Product
Table 122. Eli Lilly Recent Development
Table 123. Global Antibacterial Drugs Sales Forecast by Regions (2021-2026) (K Units)
Table 124. Global Antibacterial Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 125. Global Antibacterial Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 126. Global Antibacterial Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 127. North America: Antibacterial Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 128. North America: Antibacterial Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 129. Europe: Antibacterial Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 130. Europe: Antibacterial Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Asia Pacific: Antibacterial Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 132. Asia Pacific: Antibacterial Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 133. Latin America: Antibacterial Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 134. Latin America: Antibacterial Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 135. Middle East and Africa: Antibacterial Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 136. Middle East and Africa: Antibacterial Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 137. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 138. Key Challenges
Table 139. Market Risks
Table 140. Main Points Interviewed from Key Antibacterial Drugs Players
Table 141. Antibacterial Drugs Customers List
Table 142. Antibacterial Drugs Distributors List
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Antibacterial Drugs Product Picture
Figure 2. Global Antibacterial Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Cephalosporins Product Picture
Figure 4. Penicillins Product Picture
Figure 5. Fluoroquinolones Product Picture
Figure 6. Macrolides Product Picture
Figure 7. Carbapenems Product Picture
Figure 8. Others Product Picture
Figure 9. Global Antibacterial Drugs Sales Market Share by Application in 2020 & 2026
Figure 10. Hospital
Figure 11. Clinics
Figure 12. Others
Figure 13. Antibacterial Drugs Report Years Considered
Figure 14. Global Antibacterial Drugs Market Size 2015-2026 (US$ Million)
Figure 15. Global Antibacterial Drugs Sales 2015-2026 (K Units)
Figure 16. Global Antibacterial Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Antibacterial Drugs Sales Market Share by Region (2015-2020)
Figure 18. Global Antibacterial Drugs Sales Market Share by Region in 2019
Figure 19. Global Antibacterial Drugs Revenue Market Share by Region (2015-2020)
Figure 20. Global Antibacterial Drugs Revenue Market Share by Region in 2019
Figure 21. Global Antibacterial Drugs Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Antibacterial Drugs Revenue in 2019
Figure 23. Antibacterial Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Antibacterial Drugs Sales Market Share by Type (2015-2020)
Figure 25. Global Antibacterial Drugs Sales Market Share by Type in 2019
Figure 26. Global Antibacterial Drugs Revenue Market Share by Type (2015-2020)
Figure 27. Global Antibacterial Drugs Revenue Market Share by Type in 2019
Figure 28. Global Antibacterial Drugs Market Share by Price Range (2015-2020)
Figure 29. Global Antibacterial Drugs Sales Market Share by Application (2015-2020)
Figure 30. Global Antibacterial Drugs Sales Market Share by Application in 2019
Figure 31. Global Antibacterial Drugs Revenue Market Share by Application (2015-2020)
Figure 32. Global Antibacterial Drugs Revenue Market Share by Application in 2019
Figure 33. North America Antibacterial Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 34. North America Antibacterial Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Antibacterial Drugs Sales Market Share by Country in 2019
Figure 36. North America Antibacterial Drugs Revenue Market Share by Country in 2019
Figure 37. U.S. Antibacterial Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 38. U.S. Antibacterial Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Antibacterial Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 40. Canada Antibacterial Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Antibacterial Drugs Market Share by Type in 2019
Figure 42. North America Antibacterial Drugs Market Share by Application in 2019
Figure 43. Europe Antibacterial Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 44. Europe Antibacterial Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Antibacterial Drugs Sales Market Share by Country in 2019
Figure 46. Europe Antibacterial Drugs Revenue Market Share by Country in 2019
Figure 47. Germany Antibacterial Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 48. Germany Antibacterial Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Antibacterial Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 50. France Antibacterial Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Antibacterial Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 52. U.K. Antibacterial Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Antibacterial Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 54. Italy Antibacterial Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Antibacterial Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 56. Russia Antibacterial Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Antibacterial Drugs Market Share by Type in 2019
Figure 58. Europe Antibacterial Drugs Market Share by Application in 2019
Figure 59. Asia Pacific Antibacterial Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 60. Asia Pacific Antibacterial Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Antibacterial Drugs Sales Market Share by Region in 2019
Figure 62. Asia Pacific Antibacterial Drugs Revenue Market Share by Region in 2019
Figure 63. China Antibacterial Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 64. China Antibacterial Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Antibacterial Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 66. Japan Antibacterial Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Antibacterial Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 68. South Korea Antibacterial Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Antibacterial Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 70. India Antibacterial Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Antibacterial Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 72. Australia Antibacterial Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Antibacterial Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 74. Taiwan Antibacterial Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Antibacterial Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 76. Indonesia Antibacterial Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Antibacterial Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 78. Thailand Antibacterial Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Antibacterial Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 80. Malaysia Antibacterial Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Antibacterial Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 82. Philippines Antibacterial Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Antibacterial Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 84. Vietnam Antibacterial Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Antibacterial Drugs Market Share by Type in 2019
Figure 86. Asia Pacific Antibacterial Drugs Market Share by Application in 2019
Figure 87. Latin America Antibacterial Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 88. Latin America Antibacterial Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Antibacterial Drugs Sales Market Share by Country in 2019
Figure 90. Latin America Antibacterial Drugs Revenue Market Share by Country in 2019
Figure 91. Mexico Antibacterial Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 92. Mexico Antibacterial Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Antibacterial Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 94. Brazil Antibacterial Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Antibacterial Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 96. Argentina Antibacterial Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America Antibacterial Drugs Market Share by Type in 2019
Figure 98. Latin America Antibacterial Drugs Market Share by Application in 2019
Figure 99. Middle East and Africa Antibacterial Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 100. Middle East and Africa Antibacterial Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Antibacterial Drugs Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Antibacterial Drugs Revenue Market Share by Country in 2019
Figure 103. Turkey Antibacterial Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 104. Turkey Antibacterial Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Antibacterial Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 106. Saudi Arabia Antibacterial Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Antibacterial Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 108. U.A.E Antibacterial Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa Antibacterial Drugs Market Share by Type in 2019
Figure 110. Middle East and Africa Antibacterial Drugs Market Share by Application in 2019
Figure 111. North America Antibacterial Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. North America Antibacterial Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Europe Antibacterial Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Europe Antibacterial Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Asia Pacific Antibacterial Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Asia Pacific Antibacterial Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Latin America Antibacterial Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 118. Latin America Antibacterial Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Middle East and Africa Antibacterial Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 120. Middle East and Africa Antibacterial Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Porter's Five Forces Analysis
Figure 122. Channels of Distribution
Figure 123. Distributors Profiles
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed
動物用抗菌・抗生物質の世界市場（～2026年） Animal Antibacterial and Antibiotics are usually used in animal feed, antibiotic use whether for therapy or prevention of bacterial diseases, or as performance enhancers will result in antibiotic resistant micro-organisms, not only among pathogens but also among bacteria of the endogenous microflora…- 院内肺炎（HAP）治療薬の世界市場（～2026年） HAP is a type of pneumonia that is caused after 48 hours of hospitalization. HAP is one of the major challenges faced by the public healthcare system today. The disease is the second most common type of hospital-acquired infections. Pneumonia is an inflammatory condition of lungs and mainly affects …
- 泌尿生殖器治療薬の世界市場（～2026年） A medical science concerned with the study and treatment of diseases of the genital and urinary organs, especially sexually transmitted diseases. The growing prevalence of genitourinary disorders is presumed to be the high rendering impact driver of this vertical. In addition, increasing number of p…
- テネクテプラーゼ薬の世界市場（～2026年） Tenecteplase drug is an enzyme derived through recombinant DNA technology from a human cell line. This enzyme is used to treat thrombus (blood clots) it is also called as clot-busting drug. Tenecteplase is a bioengineered variant of the activase drug. It is estimated that North America dominated the…
- 自己免疫治療薬の世界市場（～2026年） Abnormal immune responses of the innate immune system can cause autoimmune diseases, which can damage body tissues and lead to abnormal organ functions. Immunological complications due to physiological processes within the human body lead to autoimmune diseases. These diseases are characterized by c…